{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T18:37:47Z","timestamp":1772131067088,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.pnpbp.2025.111404","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T06:13:04Z","timestamp":1747635184000},"page":"111404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Comparative analysis of inflammatory biomarkers in methamphetamine-associated psychosis and schizophrenia"],"prefix":"10.1016","volume":"139","author":[{"given":"Ali Baran","family":"Tanr\u0131kulu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilal","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zekiye","family":"\u00c7atak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.pnpbp.2025.111404_bb0005","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.3390\/cells11223694","article-title":"Increased lipid peroxidation and lowered antioxidant defenses predict methamphetamine induced psychosis","volume":"11","author":"Al-Hakeim","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111404_bb0010","doi-asserted-by":"crossref","first-page":"3081891","DOI":"10.1155\/2021\/3081891","article-title":"Parkinson\u2019s disease-related biomarkers that may appear in amphetamine abusers","volume":"2021","author":"Al-Rafiah","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.pnpbp.2025.111404_bb0015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.drugalcdep.2014.11.017","article-title":"Cannabis smoking and serum C-reactive protein: a quantile regressions approach based on NHANES 2005\u20132010","volume":"147","author":"Alshaarawy","year":"2015","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111404_bb0020","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in schizophrenia: proposed criteria and rationale for consensus","volume":"162","author":"Andreasen","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111404_bb0025","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1177\/0004867417748750","article-title":"A systematic review of risk factors for methamphetamine-associated psychosis","volume":"52","author":"Arunogiri","year":"2018","journal-title":"Austral. N. Z. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111404_bb0030","doi-asserted-by":"crossref","first-page":"902","DOI":"10.30773\/pi.2020.0185","article-title":"C-reactive protein\/albumin and neutrophil\/albumin ratios as novel inflammatory markers in patients with schizophrenia","volume":"17","author":"Balcioglu","year":"2020","journal-title":"Psychiatry Investig."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111404_bb0035","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/schbul\/sbac089","article-title":"Neutrophil to lymphocyte ratio in patients with a first episode of psychosis: a two-year longitudinal follow-up study","volume":"48","author":"Bioque","year":"2022","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2025.111404_bb0040","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jpsychires.2024.02.044","article-title":"Association between neutrophil to lymphocyte ratio and inflammatory biomarkers in patients with a first episode of psychosis","volume":"172","author":"Bioque","year":"2024","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2025.111404_bb0045","series-title":"Handbook of Schizophrenia Spectrum Disorders, Volume I: Conceptual Issues and Neurobiological Advances","first-page":"327","article-title":"Methamphetamine-associated psychosis: A model for biomarker discovery in schizophrenia","author":"Bousman","year":"2011"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111404_bb0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ajmg.b.30187","article-title":"Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis","volume":"136","author":"Chen","year":"2005","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111404_bb0055","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.biopsych.2023.11.029","article-title":"Immune cell alterations in psychotic disorders: a comprehensive systematic review and meta-analysis","volume":"96","author":"Clausen","year":"2024","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111404_bb0060","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.schres.2024.03.037","article-title":"Positive and negative symptoms in methamphetamine-induced psychosis compared to schizophrenia: a systematic review and meta-analysis","volume":"267","author":"Cohen-Laroque","year":"2024","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111404_bb0065","first-page":"271","article-title":"Long-term follow-up of patients treated for psychotic symptoms that persist after stopping illicit drug use","volume":"24","author":"Deng","year":"2012","journal-title":"Shanghai Arch. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111404_bb0070","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1001\/jamapsychiatry.2024.4941","article-title":"Differences in blood leukocyte subpopulations in schizophrenia: a systematic review and Meta-analysis","volume":"82","author":"Dudeck","year":"2025","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111404_bb0075","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/acps.13416","article-title":"Inflammation in first-episode psychosis: the contribution of inflammatory biomarkers to the emergence of negative symptoms, a systematic review and meta-analysis","volume":"146","author":"Dunleavy","year":"2022","journal-title":"Acta Psychiatr. Scand."},{"issue":"21","key":"10.1016\/j.pnpbp.2025.111404_bb0080","first-page":"591","article-title":"Diagnostic and statistical manual of mental disorders","volume":"21","author":"Edition","year":"2013","journal-title":"Am. Psychiatr. Assoc."},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2025.111404_bb0085","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.psychres.2006.07.011","article-title":"Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia","volume":"149","author":"Fan","year":"2007","journal-title":"Psychiatry Res."},{"issue":"19","key":"10.1016\/j.pnpbp.2025.111404_bb0090","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1001\/jama.2009.675","article-title":"Schizophrenia, substance abuse, and violent crime","volume":"301","author":"Fazel","year":"2009","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111404_bb0095","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/mp.2015.87","article-title":"C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications","volume":"21","author":"Fernandes","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111404_bb0100","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1182\/blood-2004-07-2599","article-title":"The origins of age-related proinflammatory state","volume":"105","author":"Ferrucci","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.pnpbp.2025.111404_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2022.110626","article-title":"Biological hypotheses, risk factors, and biomarkers of schizophrenia","volume":"120","author":"Fi\u0161ar","year":"2023","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111404_bb0110","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev-clinpsy-081122-013201","article-title":"Immune dysfunction in schizophrenia spectrum disorders","volume":"20","author":"Gangadin","year":"2024","journal-title":"Annu. Rev. Clin. Psychol."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111404_bb0115","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S2215-0366(23)00025-1","article-title":"Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis","volume":"10","author":"Halstead","year":"2023","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111404_bb0120","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/02791072.2016.1170249","article-title":"Risk factors for recent intimate partner violence among methamphetamine-using men and women","volume":"48","author":"Hayashi","year":"2016","journal-title":"J. Psychoactive Drugs"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111404_bb0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/can.2020.0105","article-title":"The effects of cannabinoids on pro-and anti-inflammatory cytokines: a systematic review of in vivo studies","volume":"6","author":"Henshaw","year":"2021","journal-title":"Cannab. Cannabin. Res."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111404_bb0130","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/2045125312474019","article-title":"Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review","volume":"3","author":"Higashi","year":"2013","journal-title":"Therap. Adv. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111404_bb0135","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1037\/0033-2909.134.2.301","article-title":"Methamphetamine abuse and impairment of social functioning: a review of the underlying neurophysiological causes and behavioral implications","volume":"134","author":"Homer","year":"2008","journal-title":"Psychol. Bull."},{"issue":"10","key":"10.1016\/j.pnpbp.2025.111404_bb0140","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1038\/npp.2013.94","article-title":"Evidence for shared genetic risk between methamphetamine-induced psychosis and schizophrenia","volume":"38","author":"Ikeda","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2025.111404_bb0145","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.3389\/fimmu.2018.02230","article-title":"C-reactive protein: higher during acute psychotic episodes and related to cortical thickness in schizophrenia and healthy controls","volume":"9","author":"Jacomb","year":"2018","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111404_bb0150","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2105\/AJPH.2019.305527","article-title":"Resurgent methamphetamine use at treatment admission in the United States, 2008\u20132017","volume":"110","author":"Jones","year":"2020","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.pnpbp.2025.111404_bb0155","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41398-023-02645-6","article-title":"Methamphetamine (MA) use, MA dependence, and MA-induced psychosis are associated with increasing aberrations in the compensatory immunoregulatory system and interleukin-1\u03b1 and CCL5 levels","volume":"13","author":"Kalayasiri","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111404_bb0160","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.schres.2018.12.017","article-title":"Neutrophil-to-lymphocyte ratio in schizophrenia: a systematic review and meta-analysis","volume":"206","author":"Karageorgiou","year":"2019","journal-title":"Schizophr. Res."},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111404_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132109","article-title":"The C-reactive protein\/albumin ratio as an independent predictor of mortality in patients with severe sepsis or septic shock treated with early goal-directed therapy","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pnpbp.2025.111404_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1744-9081-4-37","article-title":"The frizzled 3 gene is associated with methamphetamine psychosis in the Japanese population","volume":"4","author":"Kishimoto","year":"2008","journal-title":"Behav. Brain Funct."},{"key":"10.1016\/j.pnpbp.2025.111404_bb0175","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jpsychires.2023.07.023","article-title":"Correlation between C-reactive protein and the inflammatory ratios in acute schizophrenia inpatients: are they associated?","volume":"165","author":"Llorca-Bof\u00ed","year":"2023","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2025.111404_bb0180","article-title":"Differences in total and differential white blood cell counts and in inflammatory parameters between psychiatric inpatients with and without recent consumption of cannabinoids, opioids, or cocaine: a retrospective single-center study","volume":"42","author":"Llorca-Bof\u00ed","year":"2024","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.pnpbp.2025.111404_bb0185","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbi.2024.07.041","article-title":"White blood cell counts, ratios, and C-reactive protein among individuals with schizophrenia spectrum disorder and associations with long-term outcomes: a population-based study","volume":"122","author":"Llorca-Bof\u00ed","year":"2024","journal-title":"Brain Behav. Immun."},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111404_bb0190","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1360-0443.2002.00143.x","article-title":"Methamphetamine in Japan: the consequences of methamphetamine abuse as a function of route of administration","volume":"97","author":"Matsumoto","year":"2002","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111404_bb0195","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/15622975.2019.1583371","article-title":"Neutrophil-lymphocyte ratio, monocyte-lymphocyte ratio and platelet-lymphocyte ratio in non-affective psychosis: a meta-analysis and systematic review","volume":"21","author":"Mazza","year":"2020","journal-title":"World J. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111404_bb0200","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jamapsychiatry.2013.283","article-title":"Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study","volume":"70","author":"McKetin","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111404_bb0205","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/add.12474","article-title":"Does methamphetamine use increase violent behaviour? Evidence from a prospective longitudinal study","volume":"109","author":"McKetin","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.pnpbp.2025.111404_bb0210","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.drugalcdep.2016.01.018","article-title":"The profile of psychiatric symptoms exacerbated by methamphetamine use","volume":"161","author":"McKetin","year":"2016","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111404_bb0215","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3371\/CSRP.MICU.020813","article-title":"C-reactive protein levels in schizophrenia: a review and meta-analysis","volume":"7","author":"Miller","year":"2014","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111404_bb0220","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13363","article-title":"Lymphocyte-related ratios in methamphetamine-induced psychotic disorder in Taiwan, comparing with patients with schizophrenia","volume":"29","author":"Ng","year":"2024","journal-title":"Addict. Biol."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111404_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33361-7","article-title":"Clinical usefulness of C-reactive protein to albumin ratio in predicting 30-day mortality in critically ill patients: a retrospective analysis","volume":"8","author":"Oh","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111404_bb0230","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41537-021-00161-4","article-title":"Longitudinal association between CRP levels and risk of psychosis: a meta-analysis of population-based cohort studies","volume":"7","author":"Osimo","year":"2021","journal-title":"NPJ Schizophr."},{"key":"10.1016\/j.pnpbp.2025.111404_bb0235","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.psychres.2018.11.043","article-title":"Neutrophil\/lymphocyte, platelet\/lymphocyte and monocyte\/lymphocyte ratios in different stages of schizophrenia","volume":"271","author":"\u00d6zdin","year":"2019","journal-title":"Psychiatry Res."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111404_bb0240","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1176\/appi.ajp.22010076","article-title":"Transition from substance-induced psychosis to schizophrenia spectrum disorder or bipolar disorder","volume":"180","author":"Rognli","year":"2023","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111404_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0284156","article-title":"\u2018I no longer know that person\u2019: experiences of families living with someone using crystal methamphetamine","volume":"18","author":"Sampson","year":"2023","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111404_bb0250","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/0269881105049040","article-title":"Cannabis as a risk factor for psychosis: systematic review","volume":"19","author":"Semple","year":"2005","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111404_bb0255","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s12272-017-0897-y","article-title":"Current understanding of methamphetamine-associated dopaminergic neurodegeneration and psychotoxic behaviors","volume":"40","author":"Shin","year":"2017","journal-title":"Arch. Pharm. Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111404_bb0260","article-title":"Neutrophil-lymphocyte ratio in patients with acute schizophrenia","volume":"16","author":"Sugita","year":"2024","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111404_bb0265","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8137576","article-title":"Association between neutrophil percentage-to-albumin ratio and all-cause mortality in critically ill patients with coronary artery disease","volume":"2020","author":"Sun","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.pnpbp.2025.111404_bb0270","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3389\/fimmu.2014.00508","article-title":"Neutrophil-derived cytokines: facts beyond expression","volume":"5","author":"Tecchio","year":"2014","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111404_bb0275","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S1734-1140(09)70158-6","article-title":"Methamphetamine-induced neurotoxicity: the road to Parkinson\u2019s disease","volume":"61","author":"Thrash","year":"2009","journal-title":"Pharmacol. Rep."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111404_bb0280","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/jso.25209","article-title":"NARCA: a novel prognostic scoring system using neutrophil-albumin ratio and Ca19-9 to predict overall survival in palliative pancreatic cancer","volume":"118","author":"Tingle","year":"2018","journal-title":"J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111404_bb0285","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1196\/annals.1316.035","article-title":"Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis","volume":"1025","author":"Ujike","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111404_bb0290","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000445065","article-title":"Differences in clinical features of methamphetamine users with persistent psychosis and patients with schizophrenia","volume":"49","author":"Wang","year":"2016","journal-title":"Psychopathology"},{"key":"10.1016\/j.pnpbp.2025.111404_bb0295","article-title":"The relationship between serum cytokine levels and the degree of psychosis and cognitive impairment in patients with methamphetamine-associated psychosis in Chinese patients","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Psychol."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111404_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000511979","article-title":"Role and function of endocannabinoid system in major depressive disease","volume":"4","author":"Yarar","year":"2021","journal-title":"Med. Cannab. Cannabin."},{"issue":"13","key":"10.1016\/j.pnpbp.2025.111404_bb0305","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.3390\/molecules28134991","article-title":"The anti-inflammatory effects of Cannabis sativa extracts on LPS-induced cytokines release in human macrophages","volume":"28","author":"Zaiachuk","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.pnpbp.2025.111404_bb0310","article-title":"Neutrophil-to-lymphocyte ratio is independently associated with severe psychopathology in schizophrenia and is changed by antipsychotic administration: a large-scale cross-sectional retrospective study","volume":"11","author":"Zhou","year":"2020","journal-title":"Front. Psychol."},{"key":"10.1016\/j.pnpbp.2025.111404_bb0315","article-title":"Psychosis among individuals with methamphetamine use disorder is associated with elevated rates of hospitalizations and emergency department visits across an academic health care system","volume":"151","author":"Zito","year":"2023","journal-title":"J. Subst. Use Addict. Treatm."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625001587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625001587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T22:49:24Z","timestamp":1748990964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584625001587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":63,"alternative-id":["S0278584625001587"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111404","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative analysis of inflammatory biomarkers in methamphetamine-associated psychosis and schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111404","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111404"}}